Liyan Lv
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
Papers in
-
- Circular RNAs in diseases 5
- RNA modifications and cancer 5
- Epigenetics and DNA Methylation 2
- RNA Research and Splicing 2
-
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 4
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Xingwu Wang (5 shared papers)Ming Yang (3 shared papers)Ling Wei (3 shared papers)Nasha Zhang (3 shared papers)Ling Wei (8 shared papers)Xianrang Song (8 shared papers)Yan Zheng (2 shared papers)Jujie Sun (4 shared papers)
- Journals
- Oncotarget (3 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Molecular Cancer (2 papers)Scientific Reports (1 paper)Journal of Cellular Biochemistry (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Liyan Lv
21 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Cancer Research 913
- Molecular Biology 1.0k
- Oncology 233
- Immunology 139
- Biochemistry 38
Countries citing papers authored by Liyan Lv
This map shows the geographic impact of Liyan Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyan Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyan Lv more than expected).
Fields of papers citing papers by Liyan Lv
This network shows the impact of papers produced by Liyan Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyan Lv. The network helps show where Liyan Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Liyan Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Noncoding RNAs in gastric cancer: implications for drug resistance Hit paper breakdown → | 2020 | 351 |
| 2 | 2019 | 246 | |
| 3 | 2010 | 214 | |
| 4 | 2017 | 93 | |
| 5 | 2019 | 72 | |
| 6 | 2013 | 69 | |
| 7 | 2018 | 65 | |
| 8 | 2010 | 61 | |
| 9 | 2015 | 39 | |
| 10 | 2012 | 36 | |
| 11 | 2016 | 32 | |
| 12 | 2016 | 30 | |
| 13 | 2009 | 23 | |
| 14 | 2019 | 19 | |
| 15 | 2014 | 16 | |
| 16 | 2015 | 12 | |
| 17 | 2018 | 11 | |
| 18 | 2015 | 11 | |
| 19 | 2009 | 10 | |
| 20 | 2020 | 4 |
About Liyan Lv
Liyan Lv is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Immunology, having authored 21 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (5 papers), RNA modifications and cancer (5 papers), MicroRNA in disease regulation (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Epigenetics and DNA Methylation (2 papers), RNA Research and Splicing (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Cancer Research (913 citations), Molecular Biology (1.0k citations), Oncology (233 citations), Immunology (139 citations) and Biochemistry (38 citations). Liyan Lv has collaborated with scholars based in China and United States. Frequent co-authors include Xingwu Wang, Ming Yang, Ling Wei, Nasha Zhang, Ling Wei, Xianrang Song, Yan Zheng, Jujie Sun, Li Xie and Yue Shen. Their work appears in journals such as Oncotarget, Journal of Experimental & Clinical Cancer Research, Molecular Cancer, Scientific Reports and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.